Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Caplin Point gets Colombia nod for Softgel Capsules division

Written By Ruchika Sharma6 May 2024 1:30 PM IST

Chennai: Caplin Point Laboratories Limited has received Colombia's INVIMA approval for its Softgel Capsules division at Puducherry. The site...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

Alembic Pharma gets USFDA EIR for Panelav Oncology formulation facility

Written By Ruchika Sharma6 May 2024 11:31 AM IST

Vadodara: Alembic Pharma has announced that the Company has received an Establishment Inspection Report (EIR) from the US Food and Drug...

Cipla Recalls Cancer Drug Nilotinib in US Over Manufacturing Issue

Cipla, Glenmark recall products from American market over manufacturing issues

Written By Ruchika Sharma6 May 2024 11:09 AM IST

New Delhi: Glenmark and Cipla are recalling products from the American market over manufacturing issues, as per the US health regulator.According to...

Johnson and Johnson Agrees to Cut US Drug Prices in Deal with Trump Administration to Avoid Tariffs

JnJ submits regulatory applications to EMA for Tremfya for treatment of patients with ulcerative colitis, Crohn's disease

Written By Ruchika Sharma5 May 2024 1:30 PM IST

Beerse: Janssen-Cilag International NV, a Johnson & Johnson company, has announced it has submitted applications to the European Medicines...

Quadria Capital-Led Consortium Eyes Majority Stake in Samarth Lifesciences at Rs 4,500 Cr Valuation

Sentynl Therapeutics, a Zydus company acquires Zokinvy for Progeria from Eiger Biopharma

Written By Ruchika Sharma5 May 2024 12:00 PM IST

Ahmedabad: Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences Ltd. (Zydus Group), and Eiger...

Lupin Receives USFDA EIR with VAI Status for Goa Manufacturing Plant

Lupin unveils Rymti biosimilar Etanercept in Canada

Written By Ruchika Sharma5 May 2024 10:00 AM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Rymti, Lupin's first biosimilar in Canada, through its partner Sandoz...

Aurobindo Pharma Gets USFDA Nod for Generic Ravicti to Treat Urea Cycle Disorders

Aurobindo Pharma arm gets 7 USFDA observations for Alwar facility

Written By Ruchika Sharma4 May 2024 12:30 PM IST

Telangana: Aurobindo Pharma has informed in a recent BSE filing that the United States Food and Drug Administration (US FDA) has concluded an...

Dr. Reddys Labs Bags Health Canada Nod for Ozempic Generic, OneSource to Scale Supply

Dr Reddy's Labs unveils Doxycycline Capsules, 40 mg in US to treat inflammatory lesions of rosacea

Written By Ruchika Sharma4 May 2024 11:14 AM IST

Hyderabad: Dr Reddy's Laboratories Ltd. has announced its launch of Doxycycline Capsules, 40 mg in the U.S. market, a therapeutic generic equivalent...

Form expert panel to examine possible side effects, risk factors of Covishield vaccine; seeks plea filed in SC

Written By Ruchika Sharma3 May 2024 4:31 PM IST

New Delhi: A plea was submitted to the Supreme Court on Wednesday, urging the establishment of a medical expert panel overseen by a retired apex...

Novartis to Acquire Excellergy in USD 2 Billion Deal to Boost Food Allergy Pipeline

Novartis strengthens radioligand therapy pipeline with agreement to buy Mariana Oncology

Written By Ruchika Sharma3 May 2024 12:58 PM IST

Basel: Novartis has announced that it has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based...

Boehringer Ingelheims Vetmedin Becomes First USFDA-Approved Drug to Delay Heart Failure in Dogs

Boehringer Ingelheim gets USFDA nod for high-concentration, citrate-free formulation of Cyltezo to treat multiple chronic inflammatory diseases

Written By Ruchika Sharma2 May 2024 11:30 AM IST

The high-concentration formulation (100 mg/mL), which is now available as a pre-filled syringe or pre-filled autoinjector.

USFDA Approves Corcept Therapeutics Ovarian Cancer Drug Lifyorli

Labcorp gets USFDA nod for Companion Diagnostic for use with Pfizer hemophilia B Gene Therapy

Written By Ruchika Sharma2 May 2024 10:00 AM IST

Burlington: Labcorp has announced that the U.S. Food and Drug Administration (FDA) has approved its nAbCyte Anti-AAVRh74var HB-FE Assay, a...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok